logo-loader

Marker Therapeutics Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$138.54 m
Price
3.03 USD
Change
-3.19%
52 weeks high
9.16
52 weeks low
2.63

In brief

Marker Therapeutics Inc is a clinical-stage immuno-oncology company with the potential to significantly disrupt the current cell therapy landscape. The company is developing a portfolio of non-genetically modified, multi-antigen T cell therapies, which are able to recognize and kill heterogeneous tumors more effectively than conventional single-antigen CAR-T/TCR approaches.